INVIEW OncoRNAfusion

INVIEW OncoRNAfusion - 107

INVIEW OncoRNAfusion - detection of 107 cancer relevant RNA fusion genes.

RNA-Seq ventures into the realm of precision medicine and clinical care and is already an important diagnostic and prognostic parameters in various types of cancer. INVIEW OncoRNAfusion - 107 was designed to detect fusion events of selected genes, which are previously known prone to be effected by fusion events and are related to cancer. RNA from tissue or FFPE will be reverse transcribed into cDNA following a enrichment process.

>> Get Quote / Order

>> order Barcodes

>> Industrial-grade

Applications

Detection of well-known tumour-associated fusion events of 107 selected genes
Detection of novel fusion events, one fusion partner must be one of the 107 selected genes

Clinical applications

Molecular stratification
Guidance for treatment decisions
Assignment of patients to clinical trials
Post-treatment follow-up, especially for monitoring of multiple mutations

Highlights of INVIEW OncoRNAfusion

Enrichment of 107 genes prone to be effected by fusion events
Highly cost-effective
Optional flexible Sequencing depth for detection of low expressed genes
Individual batch size starting from one sample

>> FAQ's

>> Sample Submission

>> oncology solutions

Product Specifications & Ordering

Oncology product selection guide

Depending on the project goal, you can select the most suitable INVIEW product from us:

INVIEW Exome

Exome for detection of mutations within exomic regions

If you are working with liquid biopsy samples / cell-free DNA, then we recommend the INVIEW Liquid Biopsy Oncoexome.

Clinical Research Exome CRE V4
CRE V4 for detection of mutations within exonic regions as well as selected non-coding regions and many more

INVIEW Oncoprofiling
Oncoprofiling for cost effective detection of mutationwn within 728 selected genes related to cancer.

If you are working with liquid biopsy samples / cell-free DNA, then we recommend the INVIEW Liquid Biopsy Oncoprofiling.

INVIEW OncoRNAfusion
OncoRNAfusion for cost effective detection of fusion events involveing 107 genes prone to be effected by fusion events

Accepted starting material

Accepted starting material

Total RNA from various sources
rRNA depleted total RNA
Amount: recommended: 300 ng for fresh frozen material (400 ng for FFPE samples)
Dissolved in RNase-, DNase- and protease-free Tris-HCL buffer (pH 7.5 to pH 8.0)

Accepted starting material for RNA isolation

Tissue
Cells
Body fluids
FFPE tissue

Please note that only S1-classified material is accepted for RNA isolation ordered online. More information about the current classification of biological material can be found here (TRBA 466). Please contact us for further information on isolating RNA from material classified as S2.